28
Views
5
CrossRef citations to date
0
Altmetric
Miscellaneous

Stem cell transplantation as an approach to brain repair

Pages 1563-1582 | Published online: 25 Feb 2005

Bibliography

  • MORRISON SJ, SHAH NM, DJ: Regulatory mechanisms in stem cell biology. Cell (1997) 88:287–298.
  • WATT FM, HOGAN BL: Out of Eden: stem cells and their niches. Science (2000) 287:1427–1430.
  • WEISSMAN IL: Stem cells: units of development, units of regeneration and units in evolution. Cell (2000) 100:157–168.
  • KALYANI A, HOBSON K, RAO MS: Neuroepithelial stem cells from the embryonic spinal cord: isolation, characterization and clonal analysis. Dev. Biol. (1997) 186:202–223.
  • QIAN X, SHEN Q, GODERIE SK et al: Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron (2000) 28:69–80.
  • LILLIEN L: Neural development: instructions for neural diversity. Curr. Biol. (1997) 7:R168–R171.
  • LENDAHL U, ZIMMERMAN LB, MCKAY RD: CNS stem cells express a new class of intermediate filament protein. Cell (1990) 60:585–595.
  • DAHLSTRAND J, LARDELLI M, LENDAHL U: Nestin mRNA expression with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. Brain Res. Dev. Brain Res. (1995) 84:109–129.
  • LIN RC, MATESIC DE MARVIN M, MCKAY RD, BRUSTLE 0: Re-expression the intermediate filament nestin in reactive astrocytes. Neurobiol. Dis. (1995) 2:79-85.. KANEKO Y, SAKAKIBARA S, IMAI T et al.: Musashil: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev. Neurosci. (2000) 22:139–153.
  • KAWAGUCHI A, MIYATA T, SAWAMOTO K et al.: Nestin-EGFP transgenic mice: visualization of the self-renewal and multipotency of CNS stem cells. Ma Cell Neurosci. (2001) 17:259–273.
  • UCHIDA N, BUCK DW, HE D et al: Direct isolation of human central nervous system stem cells. Proc. Nati Acad. ScL USA (2000) 97:14720–14725.
  • DAVIS AA, TEMPLE S: A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature (1994) 372:263–266.
  • REYNOLDS BA, TETZLAFF W, WEISS: A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. j Neurosci. (1992) 12:4565–4574.
  • VESCOVI AL, REYNOLDS BA, FRASER DD, WEISS S: bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron (1993) 11:951–966.
  • GRITTI A, PARATI EA, COVA L etal.: Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. Neurosci. (1996) 16:1091–1100.
  • WEISS S, REYNOLDS BA, VESCOVI AL, MORSHEAD C, CRAIG CG, VAN DER KOOY D: Is there a neural stem cell in the mammalian forebrain? Trends. Neurosci. (1996) 19:387–393.
  • REYNOLDS BA, WEISS S: Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. (1996) 175:1–13.
  • •A key paper providing evidence that an EGF responsive CNS precursor cell has stem cell properties.
  • RAY J, PETERSON DA, SCHINSTINE, GAGE FH: Proliferation, differentiation and long-term culture of primary hippocampal neurons. Proc. Natl Acad. Sci. (1993) 90:3602–3606.
  • RAY J, GAGE FH: Spinal cord neuroblasts in response to basic fibroblast growth factor. I Neurosci. (1994) 14:3548–3564.
  • GENSBURGER C, LABOURDETTE G, SENSENBRENNER M: Brain basic fibroblast growth factor stimulates the proliferation of rat neuronal precursor cells in vitro. FEBS Lett. (1987) 217:1–5.
  • MURPHY M, DRAGO J, BARTLETT PF:Fibroblast growth factor stimulates the proliferation and differentiation of neural precursor cells in vitro. I Neurosci. Res. (1990) 25:463–475.
  • VICARIO-ABEJON C, JOHE TG, COLLAZO D, MCKAY RD: Functions of basic fibroblast growth factor and neurotrophins in the differentiation of hippocampal neurons. Neuron (1995) 15:105–114.
  • VESCOVI AL, GRITTI A, GALLI R, PARATI EA: Isolation and intracerebral grafting of nontransformed multipotential embryonic human CNS stem cells. Neuratrauma (1999) 16:689–693.
  • KALYANI AJ, PIPER D, MUJTABA T, LUCERO MT, RAO MS: Spinal cord neuronal precursors generate multiple neuronal phenotypes in culture. j Neurosci. (1998) 18:7856–7868.
  • TAUPIN P, RAY J, FISCHER WH et al: FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrineiparacrine cofactor. Neuron (2000) 28:385–397.
  • KILPATRICK TJ, BARTLETT PF: Cloning and growth of multipotential neural precursors: requirements for proliferation and differentiation. Neuron (1993) 10:255–265.
  • KILPATRICK TJ, BARTLETT PF: Cloned multipotential precursors from the mouse cerebrum require FGF-2, whereas glial restricted precursors are stimulated with either FGF-2 or EGF. j Neurosci. (1995) 15:3653–3661.
  • CICCOLINI E SVENDSEN CN: Fibroblast growth factor 2 (FGF-2) promotes acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor cells: identification of neural precursors responding to both EGF and FGF-2. j Neurosci. (1998) 18:7869–7880.
  • SANTA- OLALLAJ, COVARRUBIAS L: Basic fibroblast growth factor promotes growth factor responsiveness and survival of mesencephalic neural precursor cells. J. Neurobial (1999) 40:14–27.
  • TROPEPE V, SIBILIA M, CIRUNA BG,ROSSANT J, WAGNER EF, VAN DER KD: Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev. Biol. (1999) 208:166–188.
  • MARTENS DJ, TROPEPE V, VAN DER KOOY D: Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor-responsive neural stem cells within the embryonic forebrain germinal zone. j Neurosci. (2000) 20:1085–1095.
  • CICCOLINI F: Identification of two distinct types of multipotent neural precursors that appear sequentially during CNS development. Mal Cell Neurosci. (2001) 17:895–907.
  • WHITTEMORE SR, MORASSUTTI DJ, WALTERS WM, LIU RH, MAGNUSON DS: Mitogen and substrate differentially affect the lineage restriction of adult rat subventricular zone neural precursor cell populations. Exp. Cell Res. (1999) 252:75–95.
  • ANDERSON DJ, GAGE FH, WEISSMAN IL: Can stem cells cross lineage boundaries? Nat. Med. (2001) 7:393–395.
  • •A thought provoking consideration of some of the controversies surrounding recent stem sell transdifferentiation studies.
  • VESCOVI AL, PARATI EA, GRITTI A et al.: Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp. Neural. (1999) 156:71–83.
  • CARPENTER MK, CUI X, HU ZY, JACKSON J, SHERMAN S, SEIGER A, WAHLBERG LU: In vitro expansion of a multipotent population of human neural progenitor cells. Exp. Neural (1999) 158:265–278.
  • CALDWELL MA, HEX, WILKIE N et al:Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat. Biatechrial (2001) 19:475–479.
  • SVENDSEN CN, CALDWELL MA, SHEN J et al: Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp. Neural (1997) 148:135–146.
  • WEISS S, DUNNE C, HEWSON J et al:Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. j Neurosci. (1996) 16:7599–7609.
  • GALLI R, BORELLO U, GRITTI A etal.: Skeletal myogenic potential of human and mouse neural stem cells. Nat. Neurosci. (2000) 3:986–991.
  • SVENDSEN CN, SKEPPER J, ROSSER AE, TER BORG MG, TYRES P, RYKEN T: Restricted growth potential of rat neural precursors as compared to mouse. Brain Res. Dev. Brain Res. (1997) 99:253–258.
  • ARMSTRONG RJE, HARROWER TP HURELBRINK CB et al: Porcine neural xenografts in the immunocompetent rat: immune responses following grafting of expanded neural precursor cells. Neuroscience (2001) 106(1):197–212.
  • HARROWER TI RICHARDS A, BARKER RA: Porcine primary and expanded neural cells and aGal expression. Parkinsonism and Related Disorders (2001) Suppl. 7: S38.
  • BUC-CARON MH: Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobial Dis. (1995) 2:37–47.
  • CHALMERS-REDMAN RIVI, T, KEMP JA, FINE A: In vitro propagation and inducible differentiation of multipotential progenitor cells from human fetal brain. Neuroscience (1997) 76:1121–1128.
  • SVENDSEN CN, CLARKE DJ, ROSSER AE, DUNNETT SB: Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp. Neural (1996) 137:376–388.
  • SVENDSEN CN, TER BORG MG, ARMSTRONG RJE et al.: A new method for the rapid and long term growth of human neural precursor cells. j Neurosci. Methods (1998) 85:141–152.
  • FLAX JD, AURORAS, YANG C etal.: Engraftable human neural stem cells respond to developmental cues, replace neurons and express foreign genes. Nat. Biatechrial (1998) 16:1033–1039.
  • OSTENFELD T, CALDWELL MA, PROWSE KR, LINSKENS MH, JAUNIAUX E, SVENDSEN CN: Human neural precursor cells express low levels of in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp. Neural (2000) 164:215–226.
  • VESCOVI AL, SNYDER EY: and properties of neural stem clones: plasticity in vitro and in vivo. Brain Patna. (1999) 9:569–598.
  • GALLI R, PAGANO SF, GRITTI A, VESCOVI AL: Regulation of neuronal differentiation in human CNS stem cell progeny by leukemia inhibitory factor. Dev. Neurosci. (2000) 22:86–95.
  • TEMPLE S, DAVIS AA: Isolated rat cortical progenitor cells are maintained in division in vitro by membrane-associated factors. Development (1994) 120:999–1008.
  • CALD WELL MA, SVENDSEN CN: Heparin, but not other proteoglycans potentiates the mitogenic effects of FGF-2 on mesencephalic precursor cells. Exp. Neural (1998) 152:1–10.
  • ARMSTRONG RD, OGIER WC, MALUTA J: Clinical systems for the production of human cells and tissues. Biotechnology (NY) (1995) 13:449–453.
  • KALLOS MS, BEHIE LA: Inoculation and growth conditions for high-cell-density expansion of mammalian neural stem cells in suspension bioreactors. Biatechrial Biaerig. (1999) 63:473–483.
  • KALLOS MS, BEHIE LA, VESCOVI AL: Extended serial passaging of mammalian neural stem cells in suspension bioreactors. Biatechrial Biaerig. (1999) 65:589–599.
  • PALMER TD, SCHWARTZ PH, TAUPIN E KASPAR B, STEIN SA, GAGE FH: Cell culture progenitor cells from human brain after death. Nature (2001) 411:42–43.
  • OUREDNIK V, OUREDNIK J, PARK KI et al.: Neural stem cells are uniquely suited for cell replacement and gene therapy in the CNS. Novartis Found. Symp. (2000) 231:242–262.
  • ABERG MA, RYTTSEN F, HELLGREN G et al.: Selective introduction of antisense oligonucleotides into single adult CNS progenitor cells using electroporation demonstrates the requirement of STAT3 activation for CNTF-induced gliogenesis. Mal Cell Neurosci. (2001) 17:426–443.
  • VILLA A, SNYDER EY, VESCOVI A, MARTINEZ-SERRANO A: Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Esp. Neural (2000) 161:67–84.
  • •A thorough characterisation of v-myc immortalised human NSC lines.
  • WHITTEMORE SR, SNYDER EY: Physiological relevance and functional potential of central nervous system-derived cell lines. Mal Neurobial. (1996) 12:13–38.
  • SVENDSEN CN, SMITH AG: New prospects for human stem-cell therapy in the nervous system. Trends. Neurosci. (1999) 22:357–364.
  • THOMSON JA, ITSKOVITZ-ELDOR J, SHAPIRO SS etal.: Embryonic stem cell lines derived from human blastocysts. Science (1998) 282:1145-1147. [published erratum appears in Science (1998) 282:1827].
  • ••An important paper describing thederivation of embryonic stem cells from human blastocysts.
  • REUBINOFF BE, PERA MF, FONG CY, TROUNSON A, BONGSO A: Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biatechrial (2000) 18:399–404.
  • SHAMBLOTT MJ, AXELMAN J, WANG S et al: Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sri. USA (1998) 95:13726-13731. [published erratum appears in Proc. Natl. Acad. Sri. USA (1999) 96:1162].
  • ••This paper describes the isolation ofembryonic stem cells from human primordial germ cells.
  • GARCIA AR, DEACON TW, DINSMORE J, ISACSON 0: Extensive axonal and glial fiber growth from fetal porcine cortical xenografts in the adult rat cortex. Cell Transplant. (1995) 4:515–527.
  • LEE SH, LUMELSKY N, STUDER L, AUERBACH JM, MCKAY RD: Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biatechrial (2000) 18:675–679.
  • LI M, PEVNY L, LOVELL-BADGE R, SMITH A: Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr. Biol. (1998) 8:971–974.
  • ANDREWS PW: Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. (1984) 103:285–293.
  • PLEASURE SJ, PAGE C, LEE VM: Pure,postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in differentiated neurons. J. Neurosci. (1992) 12:1802–1815.
  • FUCHS E, SEGRE JA: Stem cells: a newlease on life. Cell (2000) 100:143–155.
  • JACKSON KA, MI T, GOODELL MA: Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sri. USA (1999) 96:14482–14486.
  • BJORNSON CR, RIETZE RL, BA, MAGLI MC, VESCOVI AL: Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science (1999) 283:534–537.
  • CLARKE DL, JOHANSSON CB, WILBERTZ J et al.: Generalized potential of adult neural stem cells. Science (2000) 288:1660–1663.
  • •A key paper describing the capability of adult mouse neural stem cells to contribute to the formation chimeric mouse and chick embryos and to give rise to cells belonging to all three germ layers.
  • SANCHEZ-RAMOS J, SONG S, CARDOZO-PELAEZ F et al: Adult bone marrow stromal cells differentiate into neural cells in vitro. Esp. Neural. (2000) 164:247–256.
  • PROCKOP DJ, AZIZI SA, COLTER D, DIGIROLAMO C, KOPEN G, PHINNEY DG: Potential use of stem cells from bone marrow to repair the extracellular matrix and the central nervous system. Biochem. Soc. Trans. (2000) 28:341–345.
  • TERSKIKH AV, EASTERDAY MC, LI Let al.: From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc. Natl. Acad. Sri. USA (2001) 98:7934–7939.
  • •CDNA microarrays used to demonstrate key similarities between mouse NCSCs and haematopoietic stem cells.
  • CHU VT, GAGE FH: Chipping away at stem cells. Proc Natl. Acad. Sci. USA (2001) 98:7652–7653.
  • MORRISON SJ: Stem cell potential: cananything make anything? Curr. Biol. (2001) 11:R7–R9
  • DUNNETT SB: Repair of the damaged brain. The Alfred Meyer Memorial Lecture 1998. Neurapathal Appl. Neurobial. (1999) 25:351–362.
  • ••An excellent review discussing thepriniciples of neural transplantation with particular emphasis on PD and HD.
  • BRUSTLE O, CHOUDHARY K, K et al: Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats. Nat. Biatechrial. (1998) 16:1040–1044.
  • ROSSER AE, TYERS P, DUNNETT SB:The morphological development of neurons derived from EGF- and FGF-2- driven human CNS precursors depends on their site of integration in the neonatal rat brain. Eur. Neurosci. (2000) 12:2405–2413.
  • WINKLER C, FRICKER RA, GATES MA et al: Incorporation and glial differentiation of mouse EGF-responsive neural progenitor cells after transplantation into the embryonic rat brain. Mal Cell Neurosci. (1998) 11:99–116.
  • FRICKER RA, CARPENTER MK, WINKLER C, GRECO C, GATES MA, BJORKLUND A: Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. j. Neurosci. (1999) 19:5990–6005.
  • SUHONEN JO, PETERSON DA, RAY J, GAGE FH: Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature (1996) 383:624–627.
  • SHIHABUDDIN LS, BRUNSCH WIG JP,HOLETS VR, BUNGE MB, WHITTEMORE SR: Induction of mature neuronal properties in immortalized neuronal precursor cells following grafting into the neonatal CNS. j Neuracytal (1996) 25:101–111.
  • ONIFER SM, CANNON AB, WHITTEMORE SR: Altered differentiation of CNS neural progenitor cells after transplantation into the injured adult rat spinal cord. Cell Transplant. (1997) 6:327–338.
  • LUNDBERG C, WINKLER C, WHITTEMORE SR, BJORKLUND A: Conditionally immortalized neural progenitor cells grafted to the striatum exhibit site-specific neuronal differentiation and establish connections with the host globus pallidus. Neurobial Dis. (1996) 3:33–50.
  • LUNDBERG C, MARTINEZ-SERRANO A, CATTANEO E, MCKAY RD, BJORKLUND A: Survival, integration and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp. Neural. (1997) 145:342–360.
  • SINDEN JD, RASHID-DOUBELL F, KERSHAW TR etal.: Recovery of spatial by grafts of a conditionally immortalized hippocampal neuroepithelial cell line into the ischaemia-lesioned hippocampus. Neuroscience (1997) 81:599–608.
  • NISHINO H, BORLONGAN CV: Restoration of function by neural transplantation in the ischemic brain. Frog. Brain Res. (2000) 127:461–476.
  • BARKER RA, DUNNETT SB: Nigral grafts in animal models of Parkinson's disease. In: Neural repair; transplantation and rehabilitation. Wilson BA, Robertson IH (Eds.), Psychology Press Ltd. UK: (1999):67–92.
  • BARKER RA, DUNNETT SB: Other sources of cells for transplantation. In: repair; transplantation and rehabilitation. Wilson BA, Robertson IH (Eds.), Psychology Press Ltd. UK: (1999):203–232.
  • KORDOWER JH, FREEMAN TB, SNOW BJ etal.: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl. j. Med. (1995) 332:1118–1124.
  • FREEMAN TB, OLANOW CW, HAUSER RA et al.: Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neural (1995) 38:379–388.
  • LINDVALL O, BRUNDIN P, WIDNER H et al.: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 247:574–577.
  • KORDOWER JH, FREEMAN TB, CHEN EY etal.: Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. (1998) 13:383–393.
  • SVENDSEN CN, CALDWELL MA: Neural stem cells in the developing central nervous system: implications for cell therapy through transplantation. Frog. Brain Res. (2000) 127:13–34.
  • SINDEN JD, STROEMER P, G, PATEL S, FRENCH SJ, HODGES H: Functional repair with neural stem cells. Novartis Found. Symp. (2000) 231:270–283.
  • SAWAMOTO K, NAKAO N, KAKISHITA K et al.: Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled a nestin-GFP transgene. I Neurosci. (2001) 21:3895–3903.
  • BOUVIER MM, MYTILINEOU C: Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. I Neurosci. (1995) 15:7141–7149.
  • SINCLAIR SR, FAWCETT JW, DUNNETT SB: Dopamine cells in nigral grafts differentiate prior to implantation. Eur. Neurosci. (1999) 11:4341–4348.
  • STUDER L, TABAR V, MCKAY RD: Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. (1998) 1:290–295.
  • •Pre-differentiation of NSCs in roller tube cultures improves dopaminergic neurone yield, but functional recovery is far less than with primary grafts.
  • HYNES M, ROSENTHAL A: Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr. Opin Neurobial (1999) 9:26–36.
  • YEW, SHIMAMURA K, RUBENSTEIN JL, HYNES MA, ROSENTHAL A: FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell (1998) 93:755–766.
  • STUDER L, CSETE M, LEE SH, KABBANI N, WALIKONIS J, WOLD B, MCKAY R: Enhanced proliferation, survival and dopaminergic differentiation of CNS precursors in lowered oxygen. Neurosci. (2000) 20:7377–7383.
  • ••Indicates the importance of 02-sensinggenes in NSC behaviour.
  • MORRISON SJ, CSETE M, GROVES AK, MELEGA W, WOLD B, ANDERSON DJ: Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. j. Neurosci. (2000) 20:7370–7376.
  • WAGNER J, AKERUD P, CASTRO DS et al.: Induction of a midbrain dopaminergic phenotype in Nurrl-overexpressing neural stem cells by Type 1 astrocytes. Nat.Biatechrial (1999) 17:653–659.
  • SAKURADA K, OHSHIMA-SAKURADA M, PALMER TD, GAGE FH: Nurrl, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development (1999) 126:4017–4026.
  • SMIDT MP, ASBREUK CH, COX JJ, CHEN H, JOHNSON RL, BURBACH A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx lb. Nat. NeuroscL (2000) 3:337–341.
  • DAADI MM, WEISS S: Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain. j NeuroscL (1999) 19:4484–4497.
  • YAN J, STUDER L, MCKAY RD: Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. j Neurochem. (2001) 76:307–311.
  • DAADI M, ARCELLANA-PANLILIO MY, WEISS S: Activin co-operates with fibroblast growth factor 2 to regulate tyrosine hydroxylase expression in the basal forebrain ventricular zone progenitors. Neuroscience (1998) 86:867–880.
  • ZIGOVA T, WILLING AE, TEDESCO EM et al.: Lithium chloride induces the expression of tyrosine hydroxylase in hNT neurons. Exp. Neural. (1999) 157:251–258.
  • BAKER KA, HONG M, SADI D, MENDEZ I: Intrastriatal and intranigral grafting of hNT neurons in the 6-0HDA rat model of Parkinson's disease. Exp. Neural. (2000) 162:350–360.
  • LING ZD, POTTER ED, LIPTON JW, CARVEY PM: Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp. Neural. (1998) 149:411–423.
  • TAKAHASHI J, PALMER TD, GAGE FH: Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. Neurobial. (1999) 38:65–81.
  • SABATE O, HORELLOU P, VIGNE E, COLIN P, PERRICAUDET M, BUC-CARON MH, MALLET J: Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses. Nat. Genet. (1995) 9:256–260.
  • CORTI O, SABATE O, HORELLOU P et al.: A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors. Nat. BiatechriaL (1999) 17:349–354.
  • CLARKE DJ, DUNNETT SB: Synaptic relationships between cortical and dopaminergic inputs and intrinsic GABAergic systems within intrastriatal grafts. j Chem. Neuroarrat. (1993) 6:147–158.
  • KENDALL AL, RAYMENT FD, TORRES EM, BAKER HE RIDLEY RIVI, DUNNETT SB: Functional integration of striatal allografts in a primate model of Huntington's disease. Nat. Med. (1998) 4:727–729.
  • PALFI S, CONDE F, RICHE D et al.: Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington's disease. Nat. Med. (1998) 4:963–966.
  • ISACSON O, DUNNETT SB, A: Graft-induced behavioral recovery in an animal model of Huntington's disease. Proc. Natl. Acad. Li. USA (1986) 83:2728–2732.
  • KOPYOV OV, JACQUES S, A, DUMA CM, EAGLE KS: Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neural. (1998) 149:97–108.
  • PALFI S, NGUYEN JP, BRUGIERES P et al.: MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp. Neural. (1998) 150:272–281.
  • BACHOUD-LEVI A, BOURDET C, BRUGIERES P et al.: Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp. Neural. (2000) 161:194–202.
  • BACHOUD-LEVI AC, REMY P, NGUYEN JP et al.: Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet (2000) 356:1975–1979.
  • ••This paper provides some indication thattransplants of primary embryonic striatal tissue into patients with HD may have a functional effect.
  • ARMSTRONG RJE, WATTS C, SVENDSEN CN, DUNNETT SB, ROSSER AE: Survival, Neuronal Differentiation and fiber outgrowth of Propagated Human Neural Precursor grafts in an animal model of Huntington's Disease. Cell Transplant (2000) 9:55–64.
  • DEACON T, DINSMORE J, COSTANTINI LC, RATLIFF J, ISACSON 0: Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp. Neural. (1998) 149:28–41.
  • HURLBERT MS, GIANANI RI, HUTT, FREED CR, KADDIS FG: Neural of hNT neurons for Huntington's disease. Cell Transplant. (1999) 8:143–151.
  • JAIN M, ARMSTRONG RJE, BARKER RA, ROSSER AE: Cellular and Molecular Mechanisms of Striatal Development. Brain Res. Bull. (2001) In Press.
  • GRUBB NR, O'CARROLL R, COBBE SM, SIREL J, FOX KA: Chronic memory impairment after cardiac arrest outside hospital. BMJ(1996) 313:143–146.
  • REMPEL-CLOWER NL, ZOLA SM, SQUIRE LR, AMARAL DG: Three cases of enduring memory impairment after bilateral damage limited to the hippocampal formation. j Neurosci. (1996) 16:5233–5255.
  • ZOLA-MORGAN S, SQUIRE LR, AMARAL DG: Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. Neurosci. (1986) 6:2950–2967.
  • PULSINELLI WA, BRIERLEY JB, PLUM F: Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neural. (1982) 11:491–498.
  • RIDLEY RM, TIMOTHY CJ, MACLEAN CJ, BAKER HF: Conditional learning and memory impairments following neurotoxic lesion of the CA1 field of the hippocampus. Neuroscience (1995) 67:263–275.
  • NETTO CA, HODGES H, SINDEN JD etal.: Effects of fetal hippocampal field grafts on ischaemic-induced deficits in spatial navigation in the water maze. Neuroscience (1993) 54:69–92.
  • NETTO CA, HODGES H, SINDEN JD etal.: Foetal grafts from hippocampal regio superior alleviate ischaemic- induced behavioural deficits. Behav. Brain Res. (1993) 58:107–112.
  • VIRLEY D, RIDLEY RIVI, SINDEN JD et al.: Primary CA1 and conditionally immortal MHP36 cell grafts restore conditional discrimination learning and recall in marmosets after excitotoxic lesions of the hippocampal CA1 field. Brain (1999) 122(Pt 12):2321–2335.
  • HODGES H, SOWINSKI P, VIRLEY D et al.: Functional reconstruction of the hippocampus: fetal versus conditionally immortal neuroepithelial stem cell grafts. Novara's. Found. Symp. (2000) 231:53–65.
  • PRICE J, UWANGHO D, PETERS S, GALLOWAY D, MELLODEW K: Neurotransplantation in neurodegenerative a survey of relevant issues in developmental neurobiology Novara's Found Symp. (2000) 231:148–157.
  • VEIZOVIC T, BEECH JS, STROEMER RE WATSON WP, HODGES H: Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke (2001) 32:1012–1019.
  • BORLONGAN CV, SAPORTA S, POULOS SG, OTHBERG A, SANBERG PR: Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats. Neurareport (1998) 9:2837–2842.
  • SAPORTA S, BORLONGAN CV, SANBERG PR: Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery. Neuroscience (1999) 91:519–525.
  • BORLONGAN CV, TAJIMA Y, TROJANOWSKI JQ, LEE VM, SANBERG PR: Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line. Neurareport (1998) 9:3703–3709.
  • KONDZIOLKA D, WECHSLER L, GOLDSTEIN S et al: Transplantation of cultured human neuronal cells for patients with stroke. Neurology (2000) 55:565–569.
  • ••Preliminary report of transplantation ofhuman NT cells in to patients suffering from stroke.
  • JOHE la, HAZEL TG, MULLER T, DUGICH-DJORDJEVIC MM, MCKAY RD: Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev. (1996) 10:3129–3140.
  • YANDAVA BD, BILLINGHURST LL, SNYDER EY: 'Global' cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc. Natl. Acad. Sci. USA (1999) 96:7029–7034.
  • •The first suggestion that 'global' CNS cell therapy for demyelinating diseases may be possible with focal stem cell transplants.
  • HAMMANG JP, ARCHER DR, DUNCAN ID: Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment. Exp. Neural (1997) 147:84–95.
  • ZHANG SC, LUNDBERG C, LIPSITZ, O'CONNOR LT, DUNCAN ID: Generation of oligodendroglial progenitors from neural stem cells. j. Neuracytal (1998) 27:475–489.
  • DUBOIS-DALCQ M, MURRAY K: Why are growth factors important in oligodendrocyte physiology? Patna Biol. (Paris) (2000) 48:80–86.
  • CALAORA V, ROGISTER B, BISMUTH K et al.: Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. j Neurosci. (2001) 21:4740–4751.
  • MURRAY K, DUBOIS-DALCQ M: Emergence of oligodendrocytes from human neural spheres. j. Neurosci. Res. (1997) 50:146–156.
  • BLAKEMORE WF, SMITH PM, FRANKLIN RJ: Remyelinating the demyelinated CNS. Novara's. Found Symp. (2000) 231:289–298.
  • BRUSTLE O, JONES KN, LEARISH RD etal.: Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science (1999) 285:754–756.
  • SCOLDING N, LASSMANN H: Demyelination and remyelination. Trends Neurosci. (1996) 19:1–2.
  • SCOLDING N, FRANKLIN R, STEVENS S, HELDIN CH, COMPSTON A, NEWCOMBE J: Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain (1998) 121(Pt 12):2221–2228.
  • CHANG A, NISHIYAMA A, PETERSON J, PRINEAS J, TRAPP BD: NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.. (2000) 20:6404–6412.
  • PRINEAS JW, BARNARD RO, KWON EE, SHARER LR, CHO ES: Multiple sclerosis: remyelination of nascent lesions. Ann. Neural (1993) 33:137–151.
  • RAINE CS, WU E: Multiple sclerosis: remyelination in acute lesions. j. Neurapathal Exp. Neural (1993) 52:199–204.
  • NIEHAUS A, SHI J, GRZENKOWSKI M etal.: Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination. Ann. Neural. (2000) 48:362–371.
  • HERRERA DG, GARCIA-VERDUGO JM, ALVAREZ-BUYLLA A: Adult-derived precursors transplanted into multiple in the adult brain. Ann. Neural (1999) 46:867–877.
  • RUBIO FJ, BUENO C, VILLA A, NAVARRO B, MARTINEZ-SERRANO A: Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain. Mal Cell Neurosci. (2000) 16:1–13.
  • ABOODY KS, BROWN A, RAINOV NG et al.: From the cover: neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Li. USA (2000) 97:12846–12851.
  • SNYDER EY, YOON C, FLAX JD, MACKLIS JD: Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc. Natl. Acad. Sci. USA (1997) 94:11663–11668.
  • LACHMANN RH, PLATT FM: Substrate reduction therapy for glycosphingolipid storage disorders. Expert Opin Investig. Drugs (2001) 10:455–466.
  • SNYDER EY, TAYLOR RIVI, WOLFE JH: Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature (1995) 374:367–370.
  • LACORAZZA HD, FLAX JD, SNYDER EY, JENDOUBI M: Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat. Med. (1996) 2:424–429.
  • MCNAMARA JO: Emerging insights into the genesis of epilepsy. Nature (1999) 399:A15–A22
  • BJORKLUND A, LINDVALL 0: Cell replacement therapies for central nervous system disorders. Nat. Neurosci. (2000) 3:537–544.
  • KOKAIA M, AEBISCHER P, ELMER E et al.: Seizure suppression in kindling epilepsy by intracerebral implants of GABA- but not noradrenaline-releasing polymer matrices. Esp. Brain Res. (1994) 100:385–394.
  • LOSCHERW, EBERT U, LEHMANN H, ROSENTHAL C, NIKKHAH G: Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra. j Neurosci. Res. (1998) 51:196–209.
  • SEMKOVA I, KRIEGLSTEIN J: Neuroprotection mediated via neurotrophic factors and induction of neurotrophic. Brain Res. Brain Res. Rev (1999) 30:176–188.
  • LEONARDI ET, MYTILINEOU C: Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease. Adv. Exp. Med. Biol. (1998) 446:203–222.
  • KORDOWER JH, ISACSON O, EMERICH DF: Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible? Exp. Neural (1999) 159:4–20.
  • KORDOWER JH, PALFI S, CHEN EY et al.: Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann. Neural (1999) 46:419–424.
  • MARTINEZ-SERRANO A, LUNDBERG, HORELLOU P et al: CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: complete rescue of axotomized cholinergic neurons after transplantation into the septum. j Neurosci. (1995) 15:5668–5680.
  • MARTINEZ-SERRANO A, FISCHER W, BJORKLUND A: Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron (1995) 15:473-484.. PHILIPS MF, MATTIASSON G, WIELOCH T et al.: Neuroprotective and behavioral efficacy of nerve growth factor-transfected hippocampal progenitor cell transplants after experimental traumatic brain injury. JNeurosurg. (2001) 94:765–774.
  • ANDSBERG G, KOKAIA Z, BJORKLUND A, LINDVALL O, MARTINEZ-SERRANO A: Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells. Eur. j Neurosci. (1998) 10:2026–2036.
  • MARTINEZ-SERRANO A, BJORKLUND A: Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. j Neurosci. (1996) 16:4604–4616.
  • KORDOWER JH, CHEN EY, WINKLER et al.: Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease.. Neural (1997) 387:96–113.
  • BENEDETTI S, PIROLA B, POLLO B et al.: Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. (2000) 6:447–450.
  • HERRLINGER U, WOICIECHOWSKI, SENA-ESTEVES M et al: Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mal Ther. (2000) 1:347–357.
  • HYNES M, ROSENTHAL A: Embryonic stem cells go dopaminergic. Neuron (2000) 28(1):11–14.
  • FRAICHARD A, CHASSANDE O, BILBAUT G, DEHAV C, SAVATIER P, SAMARUT J: In vitro differentiation of embryonic stem cells into glial cells and functional neurons. j Cell Sci (1995) 108(10):3181–3188.
  • BRAZELTON TR, ROSSI FM, KESHET GI, BLAU HM: From marrow to brain: expression of neuronal phenotypes in adult mice. Science (2000) 290:1775–1779.
  • MEZEY E, CHANDROSS KJ, HARTA G, MAKI RA, McKERCHER SR: Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science (2000) 290:1779–1782.
  • SANCHEZ-RAMOS JR, SONG S, KAMATH SG, ZIGOVA T, WILLING A, CARDOZO-PELAEZ F, STEDEFORD T: Expression of neural markers in human umbilical cord blood. Exp. Neural (2001) 171(1): 109–115.
  • BLACK IB, WOODBURY D: Adult Rat and Human Bone Marrow Strome' Stem Cells Differentiate into Neurons. Blood Cells Mal Dis. (2001) 27(3):632–636.
  • WENNING GK, GRANATA R, PUSCHBAN Z, SCHERFLER C, POEWE W: Neural transplantation in animal models of multiple system atrophy: a review. j Neural. Trarism. Suppl. (1999) 55:103–113.
  • PHILIPS MF, MATTIASSON G, WIELOCH T et al: Neuroprotective and behavioral efficacy of nerve growth factor-transfected hippocampal progenitor cell transplants after experimental traumatic brain injury. j Neurosurg. (2001) 94(5):765–774.
  • MUIR JK RAGHUPATHI R, SAATMAN KE et al.: Terminally differentiated human neurons survive and integrate following transplantation into the traumatically injured rat brain. I Neurosurg. (1999) 16(5):403–414.
  • WHITTEMORE SR, WHITE LA: Target of neuronal differentiation in a temperature- sensitive cell line derived from medullary raphe. Brain Res. (1993) 615(1):27–40.
  • PARK KI., FLAX JD, NISSIM S, STIEG PE, SNYDER EY: Transplantation of neural progenitor and stem cells: developmental insights may suggest new therapies for spinal cord and other CNS dysfunction. Neurotrauma (1999) 16(8):675–687.
  • HENTALL ID, SAGEN J: The alleviation of pain by cell transplantation. Frog. Brain Res. (2000) 127:535–550.
  • MCDONALD JW. LIU XZ, QU Y et al: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. (1999) 5(12):1410–1412.
  • ISHII K, ISONO M, INOUE R, HORT S: Attempted gene therapy for intractable pain: dexamethasone-mediated exogenous control of 13-endorphin secretion in genetically modified cells and intrathecal transplantation. Exp. Neural (2000) 166(1):90–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.